tradingkey.logo

Hims & Hers Health Inc

HIMS
31.690USD
-2.180-6.44%
Cierre 01/09, 16:00ETCotizaciones retrasadas 15 min
7.21BCap. mercado
52.92P/E TTM

Hims & Hers Health Inc

31.690
-2.180-6.44%

Más Datos de Hims & Hers Health Inc Compañía

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

Información de Hims & Hers Health Inc

Símbolo de cotizaciónHIMS
Nombre de la empresaHims & Hers Health Inc
Fecha de salida a bolsaSep 09, 2019
Director ejecutivoDudum (Andrew)
Número de empleados1637
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 09
Dirección2269 Chestnut St
CiudadSAN FRANCISCO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal94123
Teléfono14158510195
Sitio Webhttps://www.forhims.com/
Símbolo de cotizaciónHIMS
Fecha de salida a bolsaSep 09, 2019
Director ejecutivoDudum (Andrew)

Ejecutivos de Hims & Hers Health Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.50M
+73709.00%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
171.83K
+18604.00%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
98.05K
-3084.00%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+9935.00%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+6623.00%
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Ms. Andrea Perez
Ms. Andrea Perez
Independent Director
Independent Director
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Mr. Mike Chi
Mr. Mike Chi
Chief Operating Officer
Chief Operating Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.50M
+73709.00%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
171.83K
+18604.00%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
98.05K
-3084.00%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+9935.00%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+6623.00%
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Online
589.10M
98.35%
Wholesale
9.88M
1.65%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
598.98M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Online
589.10M
98.35%
Wholesale
9.88M
1.65%

Estadísticas de accionistas

Actualizado: sáb., 15 de nov
Actualizado: sáb., 15 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
Otro
61.71%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
Otro
61.71%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
53.26%
Investment Advisor/Hedge Fund
13.37%
Research Firm
12.70%
Hedge Fund
10.85%
Individual Investor
6.37%
Pension Fund
1.81%
Bank and Trust
1.46%
Sovereign Wealth Fund
0.74%
Private Equity
0.23%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1031
207.42M
94.59%
-8.21M
2025Q3
970
195.39M
89.11%
-889.66K
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
2023Q3
444
160.41M
78.97%
-33.55M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
22.09M
10.07%
+414.70K
+1.91%
Sep 30, 2025
The Vanguard Group, Inc.
19.47M
8.88%
+841.15K
+4.51%
Sep 30, 2025
Capital World Investors
18.78M
8.57%
+223.89K
+1.21%
Sep 30, 2025
JP Morgan Asset Management
12.87M
5.87%
+12.26M
+2026.69%
Sep 30, 2025
Farallon Capital Management, L.L.C.
10.75M
4.9%
+2.53M
+30.84%
Sep 30, 2025
Dudum (Andrew)
9.50M
4.33%
+73.71K
+0.78%
Dec 15, 2025
Renaissance Technologies LLC
9.10M
4.15%
+2.23M
+32.42%
Sep 30, 2025
Goldman Sachs & Company, Inc.
8.54M
3.9%
+998.73K
+13.24%
Sep 30, 2025
State Street Investment Management (US)
7.17M
3.27%
+132.38K
+1.88%
Sep 30, 2025
Morgan Stanley & Co. LLC
5.93M
2.71%
+1.88M
+46.43%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
First Trust Nasdaq Lux Digi Health Solutions ETF
3.83%
Global X HealthTech ETF
3.75%
Amplify Weight Loss Drug & Treatment ETF
3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
3.66%
YieldMax Ultra Option Income Strategy ETF
2.96%
Invesco S&P MidCap 400 Pure Growth ETF
2.4%
State Street SPDR S&P Health Care Services ETF
1.94%
Amplify Online Retail ETF
1.85%
Invesco S&P MidCap 400 GARP ETF
1.65%
VanEck Social Sentiment ETF
1.53%
Ver más
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción3.83%
Global X HealthTech ETF
Proporción3.75%
Amplify Weight Loss Drug & Treatment ETF
Proporción3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción3.66%
YieldMax Ultra Option Income Strategy ETF
Proporción2.96%
Invesco S&P MidCap 400 Pure Growth ETF
Proporción2.4%
State Street SPDR S&P Health Care Services ETF
Proporción1.94%
Amplify Online Retail ETF
Proporción1.85%
Invesco S&P MidCap 400 GARP ETF
Proporción1.65%
VanEck Social Sentiment ETF
Proporción1.53%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Hims & Hers Health Inc?

Los cinco principales accionistas de Hims & Hers Health Inc son:
BlackRock Institutional Trust Company, N.A. posee 22.09M acciones, lo que representa el 10.07% del total de acciones.
The Vanguard Group, Inc. posee 19.47M acciones, lo que representa el 8.88% del total de acciones.
Capital World Investors posee 18.78M acciones, lo que representa el 8.57% del total de acciones.
JP Morgan Asset Management posee 12.87M acciones, lo que representa el 5.87% del total de acciones.
Farallon Capital Management, L.L.C. posee 10.75M acciones, lo que representa el 4.90% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Hims & Hers Health Inc?

Los tres principales tipos de accionista de Hims & Hers Health Inc son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors

¿Cuántas instituciones poseen acciones de Hims & Hers Health Inc (HIMS)?

A fecha de 2025Q4, 1031 instituciones poseen acciones de Hims & Hers Health Inc, con un valor de mercado combinado de aproximadamente 207.42M, lo que representa el 94.59% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en 5.48%.

¿Cuál es la mayor fuente de ganancias de Hims & Hers Health Inc?

El FY2025Q3, el segmento empresarial Online generó la ganancia más alta para Hims & Hers Health Inc, ascendiendo a 589.10M y representando el 98.35% de la ganancia total.
KeyAI